Elevai Labs Inc. Common S... (ELAB)
Elevai Labs Common Stock Statistics
Share Statistics
Elevai Labs Common Stock has 707.08K shares outstanding. The number of shares has increased by 7209.76% in one year.
| Shares Outstanding | 707.08K |
| Shares Change (YoY) | 7209.76% |
| Shares Change (QoQ) | 31.42% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 701.76K |
| Failed to Deliver (FTD) Shares | 13.31K |
| FTD / Avg. Volume | 2.55% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is null. Elevai Labs Common Stock's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 19.16 |
| P/FCF Ratio | -23.25 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Elevai Labs Common Stock.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.
| Current Ratio | 3.36 |
| Quick Ratio | 3.85 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 5.46 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $0 |
| Employee Count | 2 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -98.23% in the last 52 weeks. The beta is -1.24, so Elevai Labs Common Stock's price volatility has been lower than the market average.
| Beta | -1.24 |
| 52-Week Price Change | -98.23% |
| 50-Day Moving Average | 5.19 |
| 200-Day Moving Average | 25.78 |
| Relative Strength Index (RSI) | 29.65 |
| Average Volume (20 Days) | 522.41K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -4.02M |
| Net Income | 0 |
| EBITDA | -4.02M |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 3.98M in cash and 0 in debt, giving a net cash position of 3.98M.
| Cash & Cash Equivalents | 3.98M |
| Total Debt | 0 |
| Net Cash | 3.98M |
| Retained Earnings | -13.27M |
| Total Assets | 8.99M |
| Working Capital | 4.25M |
Cash Flow
In the last 12 months, operating cash flow was -5.49M and capital expenditures -9.16K, giving a free cash flow of -5.49M.
| Operating Cash Flow | -5.49M |
| Capital Expenditures | -9.16K |
| Free Cash Flow | -5.49M |
| FCF Per Share | -0.69 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ELAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ELAB.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Mar 10, 2025. It was a backward split with a ratio of 1:7.
| Last Split Date | Mar 10, 2025 |
| Split Type | backward |
| Split Ratio | 1:7 |
Scores
| Altman Z-Score | -2.29 |
| Piotroski F-Score | 2 |